Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 6-(1,3-Benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine | IC50 | 39.0 [1], 63.0 [2] | |
| CID 46926514 | IC50 | 68.0 [1], 130.0 [2] | |
| 6-(3-Methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine | IC50 | 891.0 [1], 1051.0 [2] | |
| 6-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine | IC50 | 126.0 [1], 141.0 [2] | |
| 6-(Furan-2-yl)-N-(thiophen-2-ylmethyl)quinazolin-4-amine | IC50 | 250.0 [1], 1090.0 [2] | |
MLA | "Quest Database™ Dual specificity protein kinase CLK4 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 14 Nov. 2025, https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk4-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, November 14). Quest Database™ Dual specificity protein kinase CLK4 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk4-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |